Delcath Systems
Closed
566 Queensbury Ave Ste 22C
Queensbury, NY 12804
Delcath Systems develops of perfusion technology for organ and region-specific delivery of therapeutic agents. The company s intellectual property portfolio consists of 12 patents on a worldwide basis, including the United States, Europe, Asia and Canada. Its primary objective is to establish the use of the Delcath system as the standard technique for delivering chemotherapy agents to the liver. Delcath Systems also performs research for the treatment of other liver diseases and cancers in other parts of the body. The company s staff features scientific advisors, technicians and managers. It is headquartered in Stamford, Conn.
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.